StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Canaccord Genuity Upgrades Regeneron Pharma (REGN) to Buy
May 5, 2017 6:03 AM
Canaccord Genuity upgraded Regeneron Pharma (NASDAQ: REGN) from Hold to ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change
Upgrades
Next Articles
Regeneron Pharma (REGN) PT Raised to $400 at Barclays Following 1Q Report; 'Initial Strength of the Dupixent Launch'
May 5, 2017 2:46 PM